UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549





                                    FORM 8-K

                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


       DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 17, 2003


                        N-VIRO INTERNATIONAL CORPORATION
               (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)


     DELAWARE                     0-21802                   34-1741211
  (STATE  OR  OTHER  JURISDICTION (COMMISSION           (IRS  EMPLOYER
   OF  INCORPORATION)            FILE  NUMBER)    IDENTIFICATION  NO.)


     3450  W.  CENTRAL  AVENUE,  SUITE  328
             TOLEDO,  OHIO                                     43606
     (ADDRESS  OF  PRINCIPAL  EXECUTIVE  OFFICES)          (ZIP  CODE)


         REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:  (419) 535-6374







ITEM  5.     OTHER  EVENTS

N-Viro  International Corporation announced today in a press release the results
of  voting  and other events at the Annual Stockholders meeting held on November
13,  2003,  which  is  attached  as  Exhibit  99.1.


                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has  duly  caused  this  report  to  be  signed on its behalf by the undersigned
hereunto  duly  authorized.

                        N-VIRO INTERNATIONAL CORPORATION

Dated:          November  17,  2003          By:       /s/  James  K.  McHugh
                -------------------                  ------------------------
                                                       James  K.  McHugh
                                                    Chief  Financial  Officer



                                                       Exhibit  99.1
                                                       -------------

                       NEWS RELEASE FOR IMMEDIATE RELEASE
                          For More Information Contact:
     Terry J. Logan, Ph.D., N-Viro International Corp., tlogan@nviro.com (419)
                                                                      535-6374


             N-VIRO ANNOUNCES PRIVATE PLACEMENT AND CHANGES TO BOARD

Toledo,  Ohio,  November 17, 2003  - N-Viro International Corp. (OTC BB/NVIC.OB)
announced  at  its  annual meeting last Thursday that its Board had authorized a
private equity placement for stock, the proceeds of which will be used to retire
debt,  increase  working  capital  and  fund  future  business  promotion  and
development.  Although the Company has yet to identify a specific purchaser, the
Company  hopes  to  complete  a  private  placement  of equity securities of the
Company  by  the  end  of  the  year.

N-Viro  also  announced the election of Mr. Phil Levin as Chairman of the Board.
Mr.  Levin is the President of both Levin Development Company and MGM Consulting
Services,  a  real  estate  development  and  financial  consulting  company,
respectively,  in Troy, Michigan.  Mr. Levin holds an MBA in both accounting and
finance,  and  was  a  partner-in-charge  of  PriceWaterhouseCoopers' consulting
division  in  Michigan  for 16 years.  Mr. Levin has served as a Director of the
Company since November 2002 and is a member of the Audit, Nominating and Finance
Committees.  He  currently  chairs  the  Audit  and  Nominating  Committees.

Mr. Chris Anderson was elected to the Board to fill the position previously held
by  Mr.  Jack  Irmscher.  Mr.  Anderson  graduated summa cum laude from The Ohio
State  University  with BS and MS degrees in agribusiness, and also holds an MBA
from Harvard University.  Among other professional experiences, Mr. Anderson was
senior  vice  president  for  the  Andersons, a Toledo-based public company with
sales  in  excess  of  $1  billion.  Mr.  Anderson  is a member of the Audit and
Nominating  Committees,  and  is  the chair of the Corporate Planning committee.

Dr.  Logan,  President and CEO of the Company, stated, "N-Viro is very fortunate
to  attract  directors  of  the  caliber  of  Phil  Levin and Chris Anderson. In
addition,  Mr. Brian Burns, who was elected to the Board earlier this year, also
brings  strong  business  credentials  and experience to the directorship of the
Company.  In  electing Mr. Levin Chairman of our Board, and with the addition of
Messrs.  Anderson  and  Burns,  the Company has positioned itself to move to the
next  level."

The  Company  also announced the results of voting by stockholders at the Annual
Meeting  of  the  Company  held  on Thursday, November 13, 2003. Six issues were
presented  for  stockholder  consideration  at  such meeting. These were (1) the
approval  of  an  amendment  to  the  Amended  and  Restated  Certificate  of
Incorporation  of the Company to decrease the number of directors of the Company
to  between  seven  and nine, (2) the approval of an amendment to the By-laws of
the  Company to reduce the number of classes of directors from three to two, (3)
the  approval  of a compensation plan for non-employee directors of the Company,
(4)  the  ratification  of  Hausser  +  Taylor, LLP as the Company's independent
certified  public accountants, (5) the election of two directors to the board of
directors of the Company, and (6) the approval of a new stock option plan of the
Company.  The  first  five  matters  were  approved at the annual meeting by the
affirmative  vote  of  the holders of a majority of the shares of voting, common
stock  issued  and  outstanding.  The stock option plan proposed by the board of
directors for approval by the stockholders failed to receive a sufficient number
of  votes  for  adoption.

Based  on  actions taken by the stockholders at the annual meeting, the board of
directors  of  the  Company  now  consists  of seven members, which members are:
Terry  Logan,  president  of  the  Company,  Michael  Nicholson, chief operating
officer  of  the  Company,  Philip  Levin, Chairman of the Board of the Company,
Brian  Burns,  Christopher  Anderson,  Daniel  Haslinger and R. Francis DiPrete.
Messrs.  Logan,  Nicholson,  Levin  and  Burns have terms expiring in 2004 while
Messrs.  DiPrete,  Haslinger  and  Anderson  have  terms  expiring  in  2005.

N-Viro  International  Corporation  develops  and  licenses  its  technology  to
municipalities  and  private  companies.  N-Viro's  patented  processes use lime
and/or  mineral-rich, combustion byproducts to treat, pasteurize, immobilize and
convert  wastewater  sludge  and  other  bio-organic  wastes  into  biomineral
agricultural  and  soil-enrichment  products  with  real  market  value.  More
information about N-Viro International can be obtained by contacting the office,
on  the  internet  at  www.nviro.com  or  by  e-mail  inquiry to info@nviro.com.

The  Company  cautions  that  words  used  in  this  document  such  as "hopes,"
"expects,"  "anticipates,"  "believes"  and  "may," as well as similar words and
expressions used herein, identify and refer to statements describing events that
may  or  may  not occur in the future.  These forward-looking statements and the
matters  to  which  they  refer are subject to considerable uncertainty that may
cause  actual  results  to  be materially different from those described herein.
For  example, while the Company anticipates completion of a private placement of
equity  securities  prior to December 31, 2003, there are no assurances that the
Company  will  succeed in selling all or any portion of such offered securities.
Furthermore,  at the present time, the form and terms of such securities are not
known.  Likewise,  specific  purchasers  for  such  securities  have  not  been
identified.  If  the Company fails to identify appropriate purchasers for equity
securities  of  the  Company  or  fails to come to an agreement with prospective
purchasers  or  reach agreement with such purchasers as to the terms of any such
securities,  the  Company  will  not be successful in completing the anticipated
private  placement.  The  failure  to complete the anticipated private placement
could  have  an  adverse material impact upon the Company's liquidity, financial
position,  and  ability  to  continue  as  a  going  concern.


                                    -  30  -